Picture of 4D Molecular Therapeutics logo

FDMT 4D Molecular Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for 4D Molecular Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments49.7277248214288
Net Total Accounts Receivable
Net Total Receivables0.9781.490.0470
Prepaid Expenses
Total Other Current Assets
Total Current Assets52.5283256221297
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment5.055.072935.331.7
Long Term Investments
Other Long Term Assets
Total Assets58.2288353262340
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities1316.716.315.719
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities28.231.934.430.532.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity30256319231308
Total Liabilities & Shareholders' Equity58.2288353262340
Total Common Shares Outstanding